Wintest
6721
Liberta
4935
KODAMA CHEMICAL INDUSTRY
4222
GFA
8783
Good Life
2970
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 4.13%345.21B | 16.98%348.03B | 8.86%332.91B | 4.67%1.3T | 2.68%369.7B | 7.11%331.53B | 3.08%297.52B | 6.31%305.81B | 14.81%1.25T | 15.75%360.03B |
Cost of revenue | 20.99%60.74B | 54.62%55.39B | 23.52%43.96B | 25.89%159.73B | 5.53%38.12B | 49.11%50.21B | 26.54%35.82B | 23.65%35.58B | 16.39%126.88B | 17.05%36.12B |
Gross profit | 1.12%284.46B | 11.83%292.65B | 6.93%288.95B | 2.26%1.14T | 2.37%331.58B | 1.98%281.32B | 0.53%261.7B | 4.39%270.22B | 14.64%1.12T | 15.61%323.91B |
Operating expense | 11.59%281.26B | 8.79%270.28B | 9.85%264.31B | 7.23%1.02T | 6.44%276.03B | 3.10%252.04B | 6.31%248.43B | 14.17%240.61B | 13.93%948.82B | 7.47%259.34B |
Selling and administrative expenses | 1.36%257.77B | 8.21%268.35B | 10.75%267.32B | 7.15%1.02T | 5.61%275.05B | 4.20%254.32B | 5.80%247.99B | 13.93%241.37B | 14.09%950.77B | 7.55%260.44B |
-General and administrative expense | 1.36%257.77B | 8.21%268.35B | 10.75%267.32B | 7.15%1.02T | 5.61%275.05B | 4.20%254.32B | 5.80%247.99B | 13.93%241.37B | 14.09%950.77B | 7.55%260.44B |
Other operating expenses | 6,849.51%21.2B | 89.11%2.05B | 19.66%420M | -29.60%1.71B | 135.00%799M | -77.29%305M | 123.05%1.08B | -72.98%351M | -69.40%2.43B | -86.50%340M |
Total other operating income | -188.59%-2.29B | -80.40%126M | 208.18%3.43B | -30.90%3.03B | -112.85%-185M | 172.11%2.59B | -45.83%643M | -53.86%1.11B | -48.11%4.38B | -56.96%1.44B |
Operating profit | -89.07%3.2B | 68.56%22.37B | -16.82%24.64B | -25.36%127.41B | -13.98%55.54B | -6.67%29.28B | -50.20%13.27B | -38.46%29.62B | 18.75%170.7B | 66.16%64.57B |
Net non-operating interest income (expenses) | -16.79%-6.28B | -269.87%-8.93B | 141.09%2.5B | 21.91%-15.81B | 11.99%-9.6B | 20.95%-5.38B | 67.67%5.26B | -7.41%-6.09B | 42.95%-20.25B | -384.55%-10.91B |
Non-operating interest income | -52.32%1.3B | -77.83%3.26B | 263.80%9.43B | 12.68%22.2B | 868.32%2.54B | -47.08%2.72B | 30.70%14.68B | -39.93%2.59B | 314.85%19.7B | -81.43%262M |
Non-operating interest expense | -6.41%7.58B | 29.35%12.19B | -20.20%6.93B | -4.85%38.01B | 8.65%12.14B | -32.19%8.1B | 16.38%9.42B | -13.05%8.68B | -0.73%39.95B | 205.05%11.17B |
Net investment income | ||||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | 56.33%630M | -61.96%-298M | -54.21%1.66B | -13.89%3.46B | -133.28%-383M | -69.63%403M | -411.86%-184M | 144.77%3.63B | 61.82%4.02B | 24.57%1.15B |
Special income (charges) | 83.86%-361M | 36.79%-11.12B | -152.26%-10.15B | -52.98%-81.95B | -34.79%-58.4B | 68.23%-2.24B | -1,379.48%-17.59B | -99.80%-4.02B | -154.61%-53.57B | -385.30%-43.32B |
Less:Restructuring and mergern&acquisition | -388.88%-2.42B | -55.39%881M | 4.35%3.91B | -65.41%9.85B | -82.03%3.29B | -86.73%836M | -55.84%1.98B | 701.28%3.75B | 45.90%28.47B | 125.30%18.32B |
Less:Other special charges | --0 | -366.67%-8M | ---- | 99.41%-100M | -103.92%-19M | 111.61%31M | 100.06%3M | 101.57%183M | 85.86%-16.83B | 51.56%485M |
Less:Write off | 102.63%2.78B | -34.37%10.25B | 6,606.45%6.24B | 72.23%72.2B | 124.87%55.12B | 35.78%1.37B | 642.42%15.61B | -99.35%93M | 2,998.45%41.92B | 5,071.73%24.51B |
Other non-operating income (expenses) | ||||||||||
Income before tax | -112.74%-2.81B | 168.48%2.02B | -19.37%18.65B | -67.19%33.1B | -211.89%-12.85B | 17.06%22.06B | -97.38%752M | -44.82%23.13B | -51.68%100.91B | -59.86%11.48B |
Income tax | -102.64%-354M | 170.10%2.62B | -10.93%7.79B | 10.26%38.57B | 127.05%20.16B | 621.37%13.4B | -139.01%-3.73B | -40.46%8.74B | -62.78%34.98B | -55.68%8.88B |
Net income | -128.37%-2.46B | -113.29%-596M | -24.51%10.87B | -108.29%-5.47B | -1,369.46%-33.01B | -49.03%8.66B | -76.51%4.48B | -47.18%14.39B | -42.60%65.93B | -69.64%2.6B |
Net income continuous operations | -128.37%-2.46B | -113.31%-597M | -24.50%10.87B | -108.30%-5.47B | -1,369.05%-33.01B | -49.03%8.66B | -76.51%4.48B | -47.18%14.39B | -42.60%65.93B | -69.63%2.6B |
Noncontrolling interests | -19.75%1.6B | -158.21%-606M | 111.22%5.31B | -13.69%5.25B | -125.77%-301M | 87.91%1.99B | 105.33%1.04B | -24.80%2.51B | -5.97%6.08B | -39.13%1.17B |
Net income attributable to the company | -160.78%-4.05B | -99.74%9M | -53.24%5.55B | -117.90%-10.71B | -2,383.94%-32.71B | -58.13%6.67B | -81.47%3.44B | -50.31%11.88B | -44.78%59.85B | -78.44%1.43B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -160.78%-4.05B | -99.74%9M | -53.24%5.55B | -117.90%-10.71B | -2,383.94%-32.71B | -58.13%6.67B | -81.47%3.44B | -50.31%11.88B | -44.78%59.85B | -78.44%1.43B |
Gross dividend payment | ||||||||||
Basic earnings per share | -160.84%-15.35 | -99.69%0.04 | -53.27%21 | -118.14%-40.52 | -2,057.28%-123.7 | -58.03%25.23 | -81.12%13.02 | -48.63%44.94 | -42.56%223.33 | -75.25%6.32 |
Diluted earnings per share | -160.94%-15.35 | -99.69%0.04 | -53.06%20.96 | -118.26%-40.52 | -2,057.28%-123.7 | -57.76%25.19 | -81.05%12.97 | -48.57%44.65 | -42.66%221.96 | -74.61%6.32 |
Dividend per share | 0 | -11.15%69.75 | 0 | -10.14%139.5 | -28.24%61 | 0 | 11.74%78.5 | 0 | 32.13%155.25 | 26.87%85 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |